Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer

BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) is a unique subtype of this disease. Few studies focus on the feasibility of trastuzumab as maintenance or palliative therapy for patients with HER2-positive advanced GC. PATIENTS AND METHODS: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xiaomin, Zhang, Yong, Yang, Jing, Qi, Yalong, Ming, Yue, Sun, Miaomiao, Shang, Yiman, Yang, Yonghao, Zhu, Xiaoyan, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157990/
https://www.ncbi.nlm.nih.gov/pubmed/30275713
http://dx.doi.org/10.2147/OTT.S174138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157990/
https://www.ncbi.nlm.nih.gov/pubmed/30275713
http://dx.doi.org/10.2147/OTT.S174138

Ejemplares similares